Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research study

PURPOSE: We aimed to develop and translate a CD20-antigen-targeted radiopharmaceutical, Technetium-99 m-labeled ((99m)Tc) rituximab, for sentinel lymph node (SLN) detection. METHODS: (99m)Tc-rituximab was synthesized and tested for stability in human serum. The binding affinity to CD20 was evaluated...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Wang, Xuejuan, Yang, Zhi, Lin, Baohe, Zhang, Yan, Zhai, Shizhen, Zhao, Qichao, Xie, Qing, Liu, Fei, Han, Xuedi, Li, Jinfeng, Ouyang, Tao
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122431/
https://ncbi.nlm.nih.gov/pubmed/27246977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9614
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller